- Home
- MIST vs PSNL Comparison
MIST vs PSNL Comparison
Compare MIST & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- PSNL
- Stock Information
- Founded
- MIST 2003
- PSNL 2011
- Country
- MIST Canada
- PSNL United States
- Employees
- MIST N/A
- PSNL N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- PSNL Medical Specialities
- Sector
- MIST Health Care
- PSNL Health Care
- Exchange
- MIST Nasdaq
- PSNL Nasdaq
- Market Cap
- MIST 81.5M
- PSNL 321.1M
- IPO Year
- MIST N/A
- PSNL 2019
- Fundamental
- Price
- MIST $1.43
- PSNL $5.19
- Analyst Decision
- MIST Strong Buy
- PSNL Strong Buy
- Analyst Count
- MIST 3
- PSNL 4
- Target Price
- MIST $13.00
- PSNL $6.81
- AVG Volume (30 Days)
- MIST 177.8K
- PSNL 439.4K
- Earning Date
- MIST 11-11-2024
- PSNL 11-06-2024
- Dividend Yield
- MIST N/A
- PSNL N/A
- EPS Growth
- MIST N/A
- PSNL N/A
- EPS
- MIST N/A
- PSNL N/A
- Revenue
- MIST N/A
- PSNL $80,027,000.00
- Revenue This Year
- MIST N/A
- PSNL $10.85
- Revenue Next Year
- MIST N/A
- PSNL $8.77
- P/E Ratio
- MIST N/A
- PSNL N/A
- Revenue Growth
- MIST N/A
- PSNL 19.20
- 52 Week Low
- MIST $1.12
- PSNL $0.89
- 52 Week High
- MIST $3.52
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- MIST 42.50
- PSNL 56.29
- Support Level
- MIST $1.41
- PSNL $4.54
- Resistance Level
- MIST $1.53
- PSNL $5.35
- Average True Range (ATR)
- MIST 0.07
- PSNL 0.30
- MACD
- MIST -0.01
- PSNL 0.05
- Stochastic Oscillator
- MIST 26.96
- PSNL 84.71
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.